BIOMAT Database Logo BIOMAT Database Logo

Tumorigenicity of mouse T lymphoma cells is controlled by the level of major histocompatibility complex class I H-2Kk antigens. 1994

T VandenDriessche, and M Bakkus, and D Toussaint-Demylle, and K Thielemans, and H Verschueren, and P De Baetselier
Laboratory of Cellular Immunology, Free University of Brussels, Belgium.

We have previously found that an increased tumorigenicity and spontaneous metastatic potential of BW5147-derived T lymphoma cells was associated with a decrease in major histocompatibility complex (MHC) class I H-2Kk antigen expression. This suggested that H-2Kk antigens may control the tumorigenic potential of BW T lymphoma cells. Our current experiments aimed to prove this association by specifically altering H-2Kk expression by gene transfection. Transfected cells expressing a high level of H-2Kk antigens were significantly less tumorigenic and metastatic after subcutaneous inoculation. However, there was selection in vivo for cells expressing a reduced level of H-2Kk antigens, which concomitantly led to an increased tumorigenicity. These data further confirmed the strong association between H-2Kk expression and tumorigenicity. We subsequently tested whether the immune system is implicated in this phenomenon by inoculating the H-2Kk transfectants into irradiated, immunocompromised recipients. Our results indicate that the reduced tumorigenicity of the BW H-2Kk transfectants is due to an immune rejection mechanism, mediated by CD8+ immune effector cells, as revealed by in vivo depletion experiments with anti-CD8 antibodies. Hence, we hereby demonstrated that H-2Kk antigens increased the immunogenicity of BW cells, via a CD8-dependent mechanism, which consequently reduced their tumorigenicity.

UI MeSH Term Description Entries
D008212 Lymphocyte Depletion Immunosuppression by reduction of circulating lymphocytes or by T-cell depletion of bone marrow. The former may be accomplished in vivo by thoracic duct drainage or administration of antilymphocyte serum. The latter is performed ex vivo on bone marrow before its transplantation. Depletion, Lymphocyte
D009362 Neoplasm Metastasis The transfer of a neoplasm from one organ or part of the body to another remote from the primary site. Metastase,Metastasis,Metastases, Neoplasm,Metastasis, Neoplasm,Neoplasm Metastases,Metastases
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D006183 H-2 Antigens The major group of transplantation antigens in the mouse. H2 Antigens,Antigens, H-2,Antigens, H2,H 2 Antigens
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013601 T-Lymphocytes Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen. T Cell,T Lymphocyte,T-Cells,Thymus-Dependent Lymphocytes,Cell, T,Cells, T,Lymphocyte, T,Lymphocyte, Thymus-Dependent,Lymphocytes, T,Lymphocytes, Thymus-Dependent,T Cells,T Lymphocytes,T-Cell,T-Lymphocyte,Thymus Dependent Lymphocytes,Thymus-Dependent Lymphocyte
D014162 Transfection The uptake of naked or purified DNA by CELLS, usually meaning the process as it occurs in eukaryotic cells. It is analogous to bacterial transformation (TRANSFORMATION, BACTERIAL) and both are routinely employed in GENE TRANSFER TECHNIQUES. Transfections
D015139 Blotting, Southern A method (first developed by E.M. Southern) for detection of DNA that has been electrophoretically separated and immobilized by blotting on nitrocellulose or other type of paper or nylon membrane followed by hybridization with labeled NUCLEIC ACID PROBES. Southern Blotting,Blot, Southern,Southern Blot
D016399 Lymphoma, T-Cell A group of heterogeneous lymphoid tumors representing malignant transformations of T-lymphocytes. T-Cell Lymphoma,Lymphoma, T Cell,Lymphomas, T-Cell,T Cell Lymphoma,T-Cell Lymphomas
D016827 CD8 Antigens Differentiation antigens found on thymocytes and on cytotoxic and suppressor T-lymphocytes. T8 antigens are members of the immunoglobulin supergene family and are associative recognition elements in MHC (Major Histocompatibility Complex) Class I-restricted interactions. Antigens, CD8,Leu-2 Antigens,T8 Antigens, T-Cell,CD8 Antigen,Antigen, CD8,Antigens, Leu-2,Antigens, T-Cell T8,Leu 2 Antigens,T-Cell T8 Antigens,T8 Antigens, T Cell

Related Publications

T VandenDriessche, and M Bakkus, and D Toussaint-Demylle, and K Thielemans, and H Verschueren, and P De Baetselier
Cross-reactivity among evolutionarily distant major histocompatibility complex class I molecules (HLA-B27 and H-2Kk) revealed by xenoreactive T lymphocytes.
February 1993, European journal of immunology,
T VandenDriessche, and M Bakkus, and D Toussaint-Demylle, and K Thielemans, and H Verschueren, and P De Baetselier
Recognition of major histocompatibility complex class I antigens by natural killer cells.
August 1994, The Journal of experimental medicine,
T VandenDriessche, and M Bakkus, and D Toussaint-Demylle, and K Thielemans, and H Verschueren, and P De Baetselier
Tumorigenicity of hamster and mouse cells transformed by adenovirus types 2 and 5 is not influenced by the level of class I major histocompatibility antigens expressed on the cells.
December 1986, Proceedings of the National Academy of Sciences of the United States of America,
T VandenDriessche, and M Bakkus, and D Toussaint-Demylle, and K Thielemans, and H Verschueren, and P De Baetselier
Generation of major histocompatibility complex class I antigens.
January 2003, Microbes and infection,
T VandenDriessche, and M Bakkus, and D Toussaint-Demylle, and K Thielemans, and H Verschueren, and P De Baetselier
Amino acid comparison of the class I antigens of mouse major histocompatibility complex.
January 1989, Immunogenetics,
T VandenDriessche, and M Bakkus, and D Toussaint-Demylle, and K Thielemans, and H Verschueren, and P De Baetselier
Involvement of major histocompatibility complex class I antigens in T cell activation.
July 1990, European journal of immunology,
T VandenDriessche, and M Bakkus, and D Toussaint-Demylle, and K Thielemans, and H Verschueren, and P De Baetselier
Major histocompatibility complex class I antigens expressed on rat trophoblast cells.
January 1990, American journal of reproductive immunology (New York, N.Y. : 1989),
T VandenDriessche, and M Bakkus, and D Toussaint-Demylle, and K Thielemans, and H Verschueren, and P De Baetselier
Ligation of major histocompatibility complex class I antigens (MHC-I) prevents apoptosis induced by Fas or SAPK/JNK activation in T-lymphoma cells.
September 2001, Tissue antigens,
T VandenDriessche, and M Bakkus, and D Toussaint-Demylle, and K Thielemans, and H Verschueren, and P De Baetselier
Major histocompatibility complex class I-restricted alloreactive CD4+ T cells.
May 2004, Immunology,
T VandenDriessche, and M Bakkus, and D Toussaint-Demylle, and K Thielemans, and H Verschueren, and P De Baetselier
Molecules related to class-I major histocompatibility complex antigens.
January 1990, Annual review of immunology,
Copied contents to your clipboard!